{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:52:22Z","timestamp":1789051942250,"version":"build-2803163510"},"reference-count":22,"publisher":"Sociedade Brasileira de Pneumologia e Tisiologia","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Bras Pneumol."],"abstract":"<jats:p>Objective: To determine the prevalence, outcomes, and predictors of multidrug-resistant nosocomial lower respiratory tract infections (LRTI) in patients in an ICU. Methods: This was an observational cohort study involving patients with nosocomial LRTI (health care-associated pneumonia, hospital-acquired pneumonia, or ventilator-associated pneumonia). Data were prospectively collected between 2015 and 2019. The multidrug-resistant pathogens (MDRPs) identified in the isolates studied included resistant to extended-spectrum cephalosporin-resistant and carbapenem-resistant Acinetobacter baumannii, Klebsiella pneumoniae, and Pseudomonas aeruginosa, carbapenem-resistant Enterobacteriaceae, and methicillin-resistant Staphylococcus aureus at microbiological diagnosis. Results: During the study period, 267 patients in the ICU were diagnosed with LRTI, microbiological confirmation of LRTI having been obtained in 237. Of these, 146 (62%) had at least one MDRP isolate. Patients infected with MDRP were found to have poorer outcomes than patients infected with susceptible strains, such as prolonged mechanical ventilation (18.0 days vs. 12.0 days; p &lt; 0.001), prolonged ICU length of stay (23.0 days vs.16.0 days; p &lt; 0.001), and higher mortality (73% vs. 53%; p &lt; 0.001) when compared with patients infected with susceptible strains. Hospital length of stay = 5 days (OR = 3.20; 95% CI: 1.39-7.39; p = 0.005) and prolonged use vasoactive drugs (OR = 3.15; 95% CI: 1.42-7.01; p = 0.004) were independent predictors of LRTI caused by MDRPs (LRTI-MDRP). The presence of LRTI-MDRP was found to be an independent predictor of death (OR = 2.311; 95% CI: 1.091-4.894; p = 0.028). Conclusions: Prolonged use of vasoactive drugs and prolonged hospital length of stay were independent predictors of LRTI-MDRP in this population of critically ill patients with very poor outcomes.<\/jats:p>","DOI":"10.36416\/1806-3756\/e20220235","type":"journal-article","created":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T16:31:19Z","timestamp":1668097879000},"page":"e20220235","source":"Crossref","is-referenced-by-count":11,"title":["Prevalence, outcomes, and predictors of multidrug-resistant nosocomial lower respiratory tract infections among patients in an ICU"],"prefix":"10.36416","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2457-3439","authenticated-orcid":false,"given":"Ana","family":"Beatriz Souza de Oliveira1","sequence":"first","affiliation":[{"name":"1. Faculdade de Medicina de S\u00e3o Jos\u00e9 do Rio Preto \u2013 FAMERP \u2013 S\u00e3o Jos\u00e9 do Rio Preto (SP), Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8247-3116","authenticated-orcid":false,"given":"Guilherme","family":"Hirassawa Sacillotto2","sequence":"additional","affiliation":[{"name":"2. Resid\u00eancia em Medicina Intensiva, Hospital de Base, Faculdade de Medicina de S\u00e3o Jos\u00e9 do Rio Preto \u2013 FAMERP \u2013 S\u00e3o Jos\u00e9 do Rio Preto (SP), Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0776-966X","authenticated-orcid":false,"given":"Manuela","family":"Francisco Balthazar Neves2","sequence":"additional","affiliation":[{"name":"2. Resid\u00eancia em Medicina Intensiva, Hospital de Base, Faculdade de Medicina de S\u00e3o Jos\u00e9 do Rio Preto \u2013 FAMERP \u2013 S\u00e3o Jos\u00e9 do Rio Preto (SP), Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5053-9448","authenticated-orcid":false,"given":"Andressa","family":"Hellen Nora da Silva2","sequence":"additional","affiliation":[{"name":"2. Resid\u00eancia em Medicina Intensiva, Hospital de Base, Faculdade de Medicina de S\u00e3o Jos\u00e9 do Rio Preto \u2013 FAMERP \u2013 S\u00e3o Jos\u00e9 do Rio Preto (SP), Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3207-8043","authenticated-orcid":false,"given":"Tamiris","family":"Adriane Moimaz3","sequence":"additional","affiliation":[{"name":"3. Servi\u00e7o de Medicina Intensiva, Hospital de Base, Faculdade de Medicina de S\u00e3o Jos\u00e9 do Rio Preto \u2013 FAMERP \u2013 S\u00e3o Jos\u00e9 do Rio Preto (SP), Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5325-5697","authenticated-orcid":false,"given":"Joelma","family":"Villafanha Gandolfi3","sequence":"additional","affiliation":[{"name":"3. Servi\u00e7o de Medicina Intensiva, Hospital de Base, Faculdade de Medicina de S\u00e3o Jos\u00e9 do Rio Preto \u2013 FAMERP \u2013 S\u00e3o Jos\u00e9 do Rio Preto (SP), Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6070-7716","authenticated-orcid":false,"given":"Mara","family":"Correa Lelles Nogueira3","sequence":"additional","affiliation":[{"name":"3. Servi\u00e7o de Medicina Intensiva, Hospital de Base, Faculdade de Medicina de S\u00e3o Jos\u00e9 do Rio Preto \u2013 FAMERP \u2013 S\u00e3o Jos\u00e9 do Rio Preto (SP), Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2726-2441","authenticated-orcid":false,"given":"Suzana","family":"Margareth Lobo3","sequence":"additional","affiliation":[{"name":"3. Servi\u00e7o de Medicina Intensiva, Hospital de Base, Faculdade de Medicina de S\u00e3o Jos\u00e9 do Rio Preto \u2013 FAMERP \u2013 S\u00e3o Jos\u00e9 do Rio Preto (SP), Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22288","published-online":{"date-parts":[[2022,11,10]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1.            Karam G, Chastre J, Wilcox MH, Vincent JL. Antibiotic strategies in the era of multidrug resistance. Crit Care. 2016;20(1):136. https:\/\/doi.org\/10.1186\/s13054-016-1320-7","DOI":"10.1186\/s13054-016-1320-7"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2.            Cill\u00f3niz C, Torres A, Niederman MS. Management of pneumonia in critically ill patients. BMJ. 2021;375:e065871. https:\/\/doi.org\/10.1136\/bmj-2021-065871","DOI":"10.1136\/bmj-2021-065871"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3.            Palacios-Baena ZR, Giannella M, Manissero D, Rodr\u00edguez-Ba\u00f1o J, Viale P, Lopes S, et al. Risk factors for carbapenem-resistant Gram-negative bacterial infections: a systematic review. Clin Microbiol Infect. 2021;27(2):228-235. https:\/\/doi.org\/10.1016\/j.cmi.2020.10.016","DOI":"10.1016\/j.cmi.2020.10.016"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4.            Huang H, Chen B, Liu G, Ran J, Lian X, Huang X, et al. A multi-center study on the risk factors of infection caused by multi-drug resistant Acinetobacter baumannii. BMC Infect Dis. 2018;18(1):11. https:\/\/doi.org\/10.1186\/s12879-017-2932-5","DOI":"10.1186\/s12879-017-2932-5"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5.            Ponce de Leon A, Merchant S, Raman G, Avendano E, Chan J, Tepichin Hernandez G, et al. Pseudomonas infections among hospitalized adults in Latin America: a systematic review and meta-analysis. BMC Infect Dis. 2020;20(1):250. https:\/\/doi.org\/10.1186\/s12879-020-04973-0","DOI":"10.1186\/s12879-020-04973-0"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6.            Raman G, Avendano EE, Chan J, Merchant S, Puzniak L. Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis. Antimicrob Resist Infect Control. 2018;7:79. https:\/\/doi.org\/10.1186\/s13756-018-0370-9","DOI":"10.1186\/s13756-018-0370-9"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7.            STROBE Strengthening the reporting of observational studies in epidemiology [homepage on the Internet]. Bern, Switzerland: STROBE; c2021 [cited 2021 Mar 12]. STROBE checklists. Available from: http:\/\/www.strobe-statement.org\/index.php?id=available-checklists","DOI":"10.7554\/elife.08500.009"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8.            Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44 Suppl 2(Suppl 2):S27-S72. https:\/\/doi.org\/10.1086\/511159","DOI":"10.1086\/511159"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9.            American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171(4):388-416. https:\/\/doi.org\/10.1164\/rccm.200405-644ST","DOI":"10.1164\/rccm.200405-644st"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10.          ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307(23):2526-2533. https:\/\/doi.org\/10.1001\/jama.2012.5669","DOI":"10.1001\/2012.jama.11901"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11.          Ferreira FL, Bota DP, Bross A, M\u00e9lot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001;286(14):1754-1758. https:\/\/doi.org\/10.1001\/jama.286.14.1754","DOI":"10.1001\/jama.286.14.1754"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12.          Moreno RP, Metnitz PG, Almeida E, Jordan B, Bauer P, Campos RA, et al. SAPS 3--From evaluation of the patient to evaluation of the intensive care unit. Part 2: Development of a prognostic model for hospital mortality at ICU admission [published correction appears in Intensive Care Med. 2006 May;32(5):796]. Intensive Care Med. 2005;31(10):1345-1355. https:\/\/doi.org\/10.1007\/s00134-005-2763-5","DOI":"10.1007\/s00134-005-2763-5"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13.          Zilberberg MD, Shorr AF. Ventilator-associated pneumonia: the clinical pulmonary infection score as a surrogate for diagnostics and outcome. Clin Infect Dis. 2010;51 Suppl 1:S131-S135. https:\/\/doi.org\/10.1086\/653062","DOI":"10.1086\/653062"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14.          Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268-281. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03570.x","DOI":"10.1111\/j.1469-0691.2011.03570.x"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15.          Wang Z, Qin RR, Huang L, Sun LY. Risk Factors for Carbapenem-resistant Klebsiella pneumoniae Infection and Mortality of Klebsiella pneumoniae Infection. Chin Med J (Engl). 2018;131(1):56-62. https:\/\/doi.org\/10.4103\/0366-6999.221267","DOI":"10.4103\/0366-6999.221267"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16.          Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother. 2008;52(3):1028-1033. https:\/\/doi.org\/10.1128\/AAC.01020-07","DOI":"10.1128\/aac.01020-07"},{"key":"ref16","unstructured":"17.          Hu Z, Zhou S. Risk factors and etiological analysis of ventilator-associated pneumonia: three year\u2019s cases analysis of intensive care unit in county hospital [Article in Chinese]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018;30(10):933-938."},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18.          Teixeira PJ, Hertz FT, Cruz DB, Caraver F, Hallal RC, Moreira JS. Ventilator-associated pneumonia: impact of bacterial multidrug-resistance on morbidity and mortality. J Bras Pneumol. 2004;30(6):540-548. https:\/\/doi.org\/10.1590\/S1806-37132004000600009","DOI":"10.1590\/s1806-37132004000600009"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19.          Bonine NG, Berger A, Altincatal A, et al. Impact of Delayed Appropriate Antibiotic Therapy on Patient Outcomes by Antibiotic Resistance Status From Serious Gram-negative Bacterial Infections. Am J Med Sci. 2019;357(2):103-110. https:\/\/doi.org\/10.1016\/j.amjms.2018.11.009","DOI":"10.1016\/j.amjms.2018.11.009"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20.          Gon\u00e7alves Barbosa LC, Silva E Sousa JA, Bordoni GP, Barbosa GO, Carneiro LC. Elevated Mortality Risk from CRKp Associated with Comorbidities: Systematic Review and Meta-Analysis. Antibiotics (Basel). 2022;11(7):874. https:\/\/doi.org\/10.3390\/antibiotics11070874","DOI":"10.3390\/antibiotics11070874"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21.          de Kraker ME, Wolkewitz M, Davey PG, Koller W, Berger J, Nagler J, et al. Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins. J Antimicrob Chemother. 2011;66(2):398-407. https:\/\/doi.org\/10.1093\/jac\/dkq412","DOI":"10.1093\/jac\/dkq412"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22.          Filice GA, Nyman JA, Lexau C, Lees CH, Bockstedt LA, Como-Sabetti K, et al. Excess costs and utilization as-sociated with methicillin resistance for patients with Staphylococcus aureus infection. Infect Control Hosp Epidemiol. 2010;31(4):365-373. https:\/\/doi.org\/10.1086\/651094","DOI":"10.1086\/651094"}],"container-title":["Jornal Brasileiro de Pneumologia"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T16:31:27Z","timestamp":1668097887000},"score":1,"resource":{"primary":{"URL":"https:\/\/jbp.org.br\/details\/3759\/en-US\/prevalence--outcomes--and-predictors-of-multidrug-resistant-nosocomial-lower-respiratory-tract-infections-among-patients-in-an-icu"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,10]]},"references-count":22,"URL":"https:\/\/doi.org\/10.36416\/1806-3756\/e20220235","relation":{},"ISSN":["1806-3756"],"issn-type":[{"value":"1806-3756","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,10]]}}}